Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (6): 1403-1410.doi: 10.13481/j.1671-587X.20220605
• Research in basic medicine • Previous Articles Next Articles
Donghui LIU,Mingxi ZHANG,Wenliang FU,Xiumei FU,Chengjun SONG(
),Zhihong CHEN(
)
Received:2022-02-18
Online:2022-11-28
Published:2022-12-07
Contact:
Chengjun SONG,Zhihong CHEN
E-mail:songchengjun@126.com;czh1971@126.com
CLC Number:
Donghui LIU,Mingxi ZHANG,Wenliang FU,Xiumei FU,Chengjun SONG,Zhihong CHEN. Effects of sericin on injury of podocytes induced by high glucose and JNK signaling pathway[J].Journal of Jilin University(Medicine Edition), 2022, 48(6): 1403-1410.
Tab.1
Expression levels of Nephrin, MEKK1, MKK4, JNK1, and c-Jun mRNA and proteins in podocytes in various groups"
| Group | mRNA | ||||
|---|---|---|---|---|---|
| Nephrin | MEKK1 | MKK4 | JNK1 | c-Jun | |
| Normal control | 1.000±0.000 | 1.000±0.000 | 1.000±0.000 | 1.000±0.000 | 1.000±0.000 |
| Hypertonic control | 0.972±0.007 | 1.025±0.011 | 1.032±0.027 | 1.033±0.026 | 1.011±0.006 |
| High glucose | 0.551±0.008* | 2.382±0.083* | 2.147±0.015* | 2.845±0.040* | 2.949±0.020* |
| Sericin | |||||
| Low concentration | 0.661±0.007△ | 1.650±0.051△ | 1.768±0.032△ | 1.847±0.032△ | 1.948±0.021△ |
| Medium concentration | 0.746±0.004△# | 1.449±0.013△# | 1.439±0.082△# | 1.628±0.009△# | 1.696±0.012△# |
| High concentration | 0.859±0.008△#○ | 1.290±0.037△#○ | 1.361±0.101△#○ | 1.344±0.026△#○ | 1.289±0.009△#○ |
| Group | Protein | ||||
| Nephrin | MEKK1 | MKK4 | JNK1 | c-Jun | |
| Normal control | 1.200±0.097 | 0.692±0.010 | 0.508±0.048 | 3.886±0.055 | 1.629±0.085 |
| Hypertonic control | 1.197±0.040 | 0.727±0.029 | 0.498±0.045 | 4.034±0.193 | 1.574±0.065 |
| High glucose | 0.537±0.016* | 1.273±0.080* | 1.141±0.092* | 4.840±0.141* | 2.186±0.020* |
| Sericin | |||||
| Low concentration | 0.688±0.083△ | 1.080±0.086△ | 0.995±0.039△ | 4.566±0.100△ | 1.970±0.020△ |
| Medium concentration | 0.803±0.041△# | 0.928±0.025△# | 0.839±0.027△# | 4.230±0.100△# | 1.831±0.032△# |
| High concentration | 1.031±0.029△#○ | 0.824±0.053△#○ | 0.382±0.028△#○ | 3.286±0.200△#○ | 1.437±0.075△#○ |
| *P<0.05 compared with normal control group;△P<0.05 compared with high glucose group;#P<0.05 compared with low concentration of sericin group;○P<0.05 compared with medium concentration of sericin group. | |||||
Tab.2
Apoptotic rates of podocytes in various groups"
| Group | Apoptotic rate |
|---|---|
| Normal control | 6.900±0.625 |
| Hypertonic control | 11.657±1.116* |
| High glucose | 37.530±0.488* |
| Sericin | |
| Low concentration | 28.343±1.029△ |
| Medium concentration | 21.167±0.839△# |
| High concentration | 16.267±0.451△#○ |
| *P<0.05 compared with normal control group;△P<0.05 compared with high glucose group;#P<0.05 compared with low concentration of sericin group;○P<0.05 compared with medium concentration of sericin group. | |
| 1 | 宋一婵, 胡晓阳, 高彦宇, 等. 益肾阴方地子丸对早期糖尿病肾病大鼠肾脏的保护作用[J]. 中医学报, 2020, 35(8): 1737-1742. |
| 2 | 徐 维, 施海丹. 中医护理联合健康指导对糖尿病肾病患者血糖、肾功能指标及生活质量影响[J]. 实用妇科内分泌电子杂志, 2020, 7(36): 83-84. |
| 3 | HONG Q, ZHANG L, DAS B, et al. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury[J]. Kidney Int, 2018, 93(6): 1330-1343. |
| 4 | ZHONG F, CHEN H B, XIE Y F, et al. Protein S protects against podocyte injury in diabetic nephropathy[J]. J Am Soc Nephrol, 2018,29(5): 1397-1410. |
| 5 | 喻 晓, 王 镁. 中药治疗糖尿病肾病足细胞自噬机制及作用研究进展[J]. 山西中医, 2022, 38(1): 65-68. |
| 6 | LIAN H, CHENG Y, WU X Y. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice[J]. Biochem Biophys Res Commun, 2017, 487(2): 201-208. |
| 7 | 夏弋钦, 修丽梅. 基于中医古籍数据挖掘消渴病治疗奇药考[J]. 辽宁中医药大学学报, 2020, 22(9): 148-151. |
| 8 | 张亚亨, 李 慧, 刘雪乐, 等. 中药蚕茧壳的药理及临床研究进展[J]. 上海中医药杂志, 2020, 54(4): 102-105. |
| 9 | TARIQ M, TAHIR H M, BUTT S A, et al. Silk derived formulations for accelerated wound healing in diabetic mice[J]. Peer J, 2021, 9: e10232. |
| 10 | 付秀美, 钟美蓉, 付文亮, 等. 丝胶对2型糖尿病大鼠血糖和血脂的影响[J]. 中国老年学杂志, 2011, 31(1): 103-105. |
| 11 | 宋成军, 郝祥俊, 陈志宏. 丝胶对糖尿病肾病大鼠肾功能和肾脏TIMP-1表达的影响[J]. 中国老年学杂志, 2010, 30(15): 2157-2159. |
| 12 | 谢 飞, 周美兰. 羟基红花黄色素A抑制高糖诱导的小鼠肾足细胞损伤[J]. 基础医学与临床, 2021, 41(1): 27-32. |
| 13 | HARA M, OOHARA K, DAI D F, et al. Mitotic catastrophe causes podocyte loss in the urine of human diabetics[J]. Am J Pathol, 2019, 189(2): 248-257. |
| 14 | 王惠玲, 雷 迪, 赵思阳, 等. 水陆地黄胶囊通过LKB1/AMPK/Sirt1信号通路调控糖尿病肾病大鼠足细胞自噬的实验研究[J]. 环球中医药, 2021, 14(12): 2142-2148. |
| 15 | ALICIC R Z, ROONEY M T, TUTTLE K R. Diabetic kidney disease: challenges, progress, and possibilities[J]. Clin J Am Soc Nephrol, 2017, 12(12): 2032-2045. |
| 16 | 王世伟. JNK信号通路在中医药治疗糖尿病中的研究进展[J]. 医学理论与实践, 2021, 34(4): 565-567. |
| 17 | 郭 帅, 方 敬, 李雅纯, 等. 化瘀通络中药通过TAK1/JNK通路抑制巨噬细胞浸润及活化改善糖尿病肾病大鼠肾脏炎症[J]. 天然产物研究与开发, 2020, 32(12): 2020-2025. |
| 18 | LIU B, TAN P. PPAR γ/TLR4/TGF-β1 axis mediates the protection effect of erythropoietin on cyclosporin A-induced chronic nephropathy in rat[J]. Ren Fail, 2020, 42(1): 216-224. |
| 19 | 刘冬梅, 肖美先, 王海利, 等. PPAR-γ/AP-1信号通路在相关疾病中作用的研究进展[J]. 宜春学院学报, 2021, 43(6): 12-16. |
| 20 | YANG H H, KAN Q E, SU Y, et al. Long non-coding RNA CASC2 improves diabetic nephropathy by inhibiting JNK pathway[J]. Exp Clin Endocrinol Diabetes, 2019, 127(8): 533-537. |
| 21 | 杨 静, 杨玉琴, 叶 军, 等. 益气解毒活络方对早期糖尿病肾病肾小管损伤的影响[J]. 中国医院用药评价与分析, 2021, 21(12): 1482-1485, 1489. |
| 22 | 邓文荣, 石文清, 李海俏, 等. 姜黄素对糖尿病肾病大鼠肾功能及肾组织JNK、Notch2/hes1信号通路的影响[J]. 山东医药, 2020, 60(14): 5-8. |
| 23 | 马 媛, 张大鹏, 王 想, 等. lncRNA TUG1对高糖诱导的小鼠足细胞MPC5凋亡的影响[J].郑州大学学报(医学版),2019,54(6):863-866. |
| [1] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [2] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [3] | Qiuping SU,Lei XING,Wei ZHANG,Shan JIANG,Yangyang ZHAO,Fangfang CHEN. Research progress in anti-tumor mechanism of berberine and application of its novel nano-delivery system in tumor therapy [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 863-871. |
| [4] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [5] | Yaping LI,Chunyan TAN,Lujie ZHAO,Jiayi ZHAO,Ting LI,Xiao YANG,Xiaoyun YANG. Inductive effect of lysophosphatidic acid combined with 6-hydroxydopamine on apoptosis of SH-SY5Y cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 152-161. |
| [6] | Jiaxin WANG,Junwen MAO,Xuan ZHANG. Expression of natural autoantibodies against apoptosis inhibitory genes in plasma of patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 228-235. |
| [7] | Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69. |
| [8] | Shanshan SUN,Mei LU,Xinfu GAO,LYu Guangyao,Baolei Zhao,LYu Wenwen. Inhibitory effect of Bradykinin 1 receptor antagonist ELN441958 on proliferation of HepG2 cells by regulating Akt/FoxO3a signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 70-80. |
| [9] | Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9. |
| [10] | Bing BAI,Qian ZHANG,Tao PU,Yu NI,Tingting HU,Linhong HU,Yibin YANG. Effect of angiopoietin 1 and tyrosine kinase receptor 2 inhibitor on glucose transportation in endothelial cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1487-1497. |
| [11] | Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266. |
| [12] | Xun LU,Chengxin MA,Jianan YANG,Xinxin GUO,Xiaobei XIE,Binghai ZHAO,Hongzhi LI. Research progress in mechanism of podocyte injury and its potential therapeutic strategies for diabetic nephropathy [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1415-1422. |
| [13] | Jiarui LI,Zhenlin YANG,Fan GAO,Jingjing GUO,Jinzi LI. Effect of miR-34a-5p on hippocampal neuron apoptosis in rats with temporal lobe epilepsy and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 939-947. |
| [14] | Panxi SUN,Xue QIN,Chongyang ZHANG,Jia LUO,Yong CHEN,Lili WEI. Protective effect of TUG-891 on ischemic stroke induced by ischemia and hypoxia and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 968-975. |
| [15] | Cheng CHEN,Jingyao LI,Wanxiang HU,Donghui LIU,Zhihong CHEN. Protective effect of sericin on streptozotocin-induced INS-1 cell damage by regulating PI3K/Akt/NF-κB signaling pathway through Akt1 and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 590-598. |